Related Experiment Video

Updated: Jun 8, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K

Lung Cancer Screening and Precision Oncology

Susan E Bates1

  • 1Columbia University Irving Medical Center New York, NY; James J. Peters VA Medical Center Bronx, NY.

Seminars in Oncology
|November 4, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

Related Experiment Videos

Last Updated: Jun 8, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.6K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.0K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.5K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341

Articles linked to this work by shared authors, journal, and citation graph.

Phase 2 study of azacitidine plus pembrolizumab as second-line treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.

The oncologist·2026

International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

CA19-9 as a Dynamic Biomarker for Continuous Monitoring of Therapeutic Efficacy in Pancreatic Adenocarcinoma.

Cancers·2025

Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer.

JAMA network open·2025

Cancer interception during treatment: using growth kinetics to create a continuous variable for assessing disease response.

The oncologist·2025

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2025

A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategies.

Seminars in oncology·2026

Circumferential lymphadenectomy around the SMA in pancreatic head cancer: A single-center experience.

Seminars in oncology·2026

From imaging to action: MRI features direct surgical strategy in low rectal cancer.

Seminars in oncology·2026

Genetic and systems-level regulation of cancer metabolism: From metabolic reprogramming to AI-driven precision oncology.

Seminars in oncology·2026

Regulation of PD-1 and PD-L1 expression in tumor immune microenvironment.

Seminars in oncology·2026

Clostridioides difficile infection in hematologic malignancy patients with and without bone marrow transplantation: A nation-wide cross-sectional study.

Seminars in oncology·2026

Missed Pulmonary Nodules on CT: Determinants and Implications for Radiologic Practice.

AJR. American journal of roentgenology·2026

Diagnostic performance of CDO1 and ZSCAN12 methylation in endometrial versus cervical samples for endometrial cancer and atypical hyperplasia: a comparative study.

Annals of medicine·2026

The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.

Cancer·2026

Gallbladder Polyps as Precursors of Gallbladder Carcinoma: A Narrative Review for Clinical Practice.

Visceral medicine·2026

A Balloon-assisted Colonoscope does not Increase the Adenoma Miss Rate: Outcomes of a Single-center Tandem Randomized Clinical Trial.

Endoscopy international open·2026

Tumor Microenvironment-Responsive Nanoparticles for Pancreatic Cancer Imaging and Treatment.

International journal of nanomedicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us